Bryn Williams-Jones
Member of the Board of Advisors @Sable Bio
Signup · Get unlimited contacts
WORK HISTORY
Member of the Board of Advisors @Sable Bio
Prevent target safety failures with unique data insights and cutting-edge approaches. Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities. Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points. Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies.
EDUCATION
Liverpool John Moores University
BSc (Hons), Applied Biochemistry
SKILLS
ABOUT BRYN WILLIAMS-JONES
Experienced and successful drug discovery executive with over 30 years of experience in biochemistry, bioinformatics, drug discovery and development, applied AI, machine learning and data science. Proven ability to build and lead teams in exploring and launching innovative drug discovery projects. Deep knowledge of the pharmaceutical industry and a strong record of success in the development and launch of new products and platforms in the drug discovery informatics space. Deep experience of cross-industry collaboration and pre-competitive working, driver of highly applied research focus to reduce new technologies to tangible drug programme outcomes and research strategy.Key words: drug discovery | techbio | biotech | AI/ML | collaborative | multidisciplinary | strategy | leadership | network | pioneer | governance | delivery | target validation | portfolio strategy | applied innovation | scaling |
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.